Regulatory Approvals

Roche’s pTau217 single-biomarker Alzheimer’s blood test lands FDA approval

By

Regulatory Approvals — Roche’s pTau217 single-biomarker Alzheimer’s blood test lands FDA approval  Medical Device Network

Read the original at Regulatory Approvals ↗

Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. August 25, 2026.

By

Related Post

Regulatory Approvals

FDA clears Roche and Eli Lilly’s Alzheimer’s blood test for primary and specialty care

Regulatory Approvals

FDA approves new blood test for Alzheimer’s disease

Regulatory Approvals

FDA approves a new blood test to detect signs of Alzheimer’s

Financial News For All

Litigation

South Bend Chocolate Company lawsuit against SBN dismissed

Litigation

Zillow, Redfin ink last-minute antitrust settlement over FTC claims

Mergers & Acquisitions

Full Circle completes acquisition of Mac of All Trades

Mergers & Acquisitions

California cancels talks with Paramount over Warner Bros deal